About
- About Avecho
- Board & Leadership
TPM^® Technology
Portfolio
Invest
- Investor Centre
- Media Centre
Contact

Hit enter to search or ESC to close

Phosphagenics Restructures

October 12, 2015

Click here to read more

Post navigation

Phosphagenics Begins its Animal Health and Nutrition Program

Phosphagenics Signs Development Agreement with tesa Labtec for TPM/Oxymorphone Patch

Related Posts

Phosphagenics Arbitration Award Issued

November 12, 2018

2016 May 19 AGM Chairman and CEO Addresses

May 19, 2016

Investor Presentation April 2018

April 17, 2018

Recent Posts

Watch now: how significant is chronic insomnia in Australia?
October 14, 2026
Recruitent recommences for phase III insomnia trial
August 31, 2026
Euroz Hartleys | Successful Phase 3 Interim Results
July 8, 2026

Categories

Analyst Coverage
Company Announcement
Company Report
Investor Webinar
Media Coverage
Newsletter
Press Release
Uncategorised

About us

We see a future where more patients can get even more from their treatments through innovative delivery technologies.

Stay Posted

Stay informed about our latest news and developments.

Leave this field empty if you're human:

About Avecho

TPM^® Technology

Portfolio

Investor Centre
- Investor Centre
- Media Centre

© Copyright 2019 Avecho Biotechnology Ltd.